Surg Obes Relat Dis (2024) 20(7):61420
This regulation, established following a 2012 fungal meningitis outbreak linked to a compounding pharmacy, ensures higher-quality control and oversight, especially for medications intended for intravenous or epidural use
References & Sources SURPASS Clinical Trials GI Data: Tirzepatide Adverse Events Meta-Analysis: GLP-1 and Delayed Gastric Emptying Research: Ginger for Nausea Clinical Evidence: Tirzepatide StatPearls (NCBI): Johns Hopkins Ginger Benefits: SURPASS-2 Trial Results: Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice
Ozaka S, Sonoda A, Ariki S, Minata M, Kamiyama N, Hidano S, Sachi N, Ito K, Kudo Y, Dewayani A, Chalalai T, Ozaki T, Soga Y, Fukuda C, Mizukami K, Ishizawa S, Nishiyama M, Fujitsuka N, Mogami S, Kubota K, Murakami K, Kobayashi T
Because of these effects, GLP-1 receptor agonists are commonly used to treat type 2 diabetes and obesity
